Search

Your search keyword '"Bodaghi, B."' showing total 1,072 results
Start Over Author "Bodaghi, B."
1,072 results on '"Bodaghi, B."'

4. Behçet's disease uveitis

Author

Joubert, M., Desbois, A.-C., Domont, F., Ghembaza, A., Lejoncour, A., Mirouse, A., Maalouf, G., Leclercq, M., Touhami, S., Cacoub, P., Bodaghi, B., and Saadoun, D.

Published
2023
Full Text
View/download PDF

12. Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies

Author

Gocko, X., Lenormand, C., Lemogne, C., Bouiller, K., Gehanno, J.-F., Rabaud, C., Perrot, S., Eldin, C., de Broucker, T., Roblot, F., Toubiana, J., Sellal, F., Vuillemet, F., Sordet, C., Fantin, B., Lina, G., Sobas, C., Jaulhac, B., Figoni, J., Chirouze, C., Hansmann, Y., Hentgen, V., Caumes, E., Dieudonné, M., Picone, O., Bodaghi, B., Gangneux, J.-P., Degeilh, B., Partouche, H., Saunier, A., Sotto, A., Raffetin, A., Monsuez, J.-J., Michel, C., Boulanger, N., Cathebras, P., and Tattevin, P.

Published
2019
Full Text
View/download PDF

13. Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis

Author

Figoni, J., Chirouze, C., Hansmann, Y., Lemogne, C., Hentgen, V., Saunier, A., Bouiller, K., Gehanno, J.F., Rabaud, C., Perrot, S., Caumes, E., Eldin, C., de Broucker, T., Jaulhac, B., Roblot, F., Toubiana, J., Sellal, F., Vuillemet, F., Sordet, C., Fantin, B., Lina, G., Gocko, X., Dieudonné, M., Picone, O., Bodaghi, B., Gangneux, J.P., Degeilh, B., Partouche, H., Lenormand, C., Sotto, A., Raffetin, A., Monsuez, J.J., Michel, C., Boulanger, N., Cathebras, P., and Tattevin, P.

Published
2019
Full Text
View/download PDF

14. Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis

Author

Jaulhac, B., Saunier, A., Caumes, E., Bouiller, K., Gehanno, J.F., Rabaud, C., Perrot, S., Eldin, C., de Broucker, T., Roblot, F., Toubiana, J., Sellal, F., Vuillemet, F., Sordet, C., Fantin, B., Lina, G., Sobas, C., Gocko, X., Figoni, J., Chirouze, C., Hansmann, Y., Hentgen, V., Cathebras, P., Dieudonné, M., Picone, O., Bodaghi, B., Gangneux, J.P., Degeilh, B., Partouche, H., Lenormand, C., Sotto, A., Raffetin, A., Monsuez, J.J., Michel, C., Boulanger, N., Lemogne, C., and Tattevin, P.

Published
2019
Full Text
View/download PDF

25. French practical guidelines for the diagnosis and management of relapsing polychondritis

Author

Arnaud, L., primary, Costedoat-Chalumeau, N., additional, Mathian, A., additional, Sailler, L., additional, Belot, A., additional, Dion, J., additional, Morel, N., additional, Moulis, G., additional, Bader-Meunier, B., additional, Bodaghi, B., additional, Bura Riviere, A., additional, Casadevall, M., additional, Fain, O., additional, Frances, C., additional, Hachulla, E., additional, Hamidou, M., additional, Karakoglou, C., additional, Lambert, M., additional, Lerebours, F., additional, Leroux, G., additional, Mariette, X., additional, Marquette, C.H., additional, Martin, T., additional, Mekinian, A., additional, Papo, T., additional, Piette, J.-C., additional, Puechal, X., additional, Richez, C., additional, Saraux, A., additional, Seve, P., additional, Tankere, F., additional, Terriou, L., additional, and Varin, P., additional

Published
2023
Full Text
View/download PDF

26. French recommendations for the management of non-infectious chronic uveitis

Author

Quartier, P., primary, Saadoun, D., additional, Belot, A., additional, Errera, M.-H., additional, Kaplanski, G., additional, Kodjikian, L., additional, Kone-Paut, I., additional, Miceli-Richard, C., additional, Monnet, D., additional, Audouin-Pajot, C., additional, Seve, P., additional, Uettwiller, F., additional, Weber, M., additional, Bodaghi, B., additional, Abad, S., additional, Bayen, M., additional, Bielefeld, P., additional, Chalumeau, M., additional, Chiquet, C., additional, Cohen, J.-D., additional, Despert, V., additional, Devilliers, H., additional, Fardeau, C., additional, Georgin-Lavialle, S., additional, Guex-Crosier, Y., additional, Guillaume Czitrom, S., additional, Heron, E., additional, Hofer, M., additional, Agbo Kpati, K.P., additional, Labalette, P., additional, Lemelle, I., additional, Nouar, D., additional, Pugnet, G., additional, Sellam, J., additional, Sene, D., additional, Terrier, B., additional, and Trad, G.S., additional

Published
2023
Full Text
View/download PDF

39. Effet bénéfique du traitement immunosuppresseur dans les uvéites non-antérieures de la sarcoïdose

Author

Leclercq, M., primary, Sève, P., additional, Biard, L., additional, Vautier, M., additional, Domont, F., additional, Maalouf, G., additional, Leroux, G., additional, Toutée, A., additional, Fardeau, C., additional, Touhami, S., additional, Bodaghi, B., additional, Kodjikian, L., additional, Cacoub, P., additional, Saadoun, D., additional, and Desbois, A.C., additional

Published
2022
Full Text
View/download PDF

40. Anti-TNF alpha versus Tocilizumab dans la prise en charge des vascularites rétiniennes au cours des uvéites non-infectieuses : étude multicentrique BIOVAS

Author

Maalouf, G., primary, Anais, A., additional, Mathilde, L., additional, Sève, P., additional, Bielefeld, P., additional, Julie, G., additional, Thomas, S., additional, Titah, C., additional, Moulinet, T., additional, Rouviere, B., additional, Sene, D., additional, Anne-Claire, D., additional, Domont, F., additional, Sarah, T., additional, Patrice, C., additional, Laurent, K., additional, Biard, L., additional, Bodaghi, B., additional, and Saadoun, D., additional

Published
2022
Full Text
View/download PDF

41. Évaluation et comparaison du taux de rechute des uvéites non infectieuse sévères avec vascularite rétinienne et/ou Œdème maculaire traitées par INFLIXIMAB et ADALIMUMAB : une étude multicentrique de 330 patients BIOVAS

Author

Maalouf, G., primary, Anais, A., additional, Mathilde, L., additional, Sève, P., additional, Bielefeld, P., additional, Julie, G., additional, Thomas, S., additional, Titah, C., additional, Moulinet, T., additional, Rouviere, B., additional, Sene, D., additional, Anne-Claire, D., additional, Domont, F., additional, Sarah, T., additional, Patrice, C., additional, Laurent, K., additional, Biard, L., additional, Bodaghi, B., additional, and Saadoun, D., additional

Published
2022
Full Text
View/download PDF

42. Uvéites chez les patients vivant avec le VIH : une étude rétrospective multicentrique

Author

Razafinimanana, M., primary, Benjamin, L., additional, Saadoun, D., additional, Bodaghi, B., additional, Toutée, A., additional, Caumes, E., additional, Katlama, C., additional, Pourcher, V., additional, Sève, P., additional, Cotte, L., additional, Kodjikian, L., additional, Serrar, Y., additional, Devilliers, H., additional, Bielefeld, P., additional, Mouries-Martin, S., additional, Jaussaud, R., additional, Angioi-Duprez, K., additional, and Moulinet, T., additional

Published
2022
Full Text
View/download PDF

43. Prise en charge de la toxoplasmose oculaire en France : résultats d’une étude Delphi modifiée

Author

Schaeffer, M., primary, Ballonzoli, L., additional, Gaucher, D., additional, Arndt, C., additional, Angioi-Duprez, K., additional, Baudonnet, R., additional, Bodaghi, B., additional, Bron, A., additional, Chiambaretta, F., additional, Cimon, B., additional, Chiquet, C., additional, Creuzot-Garcher, C., additional, Daien, V., additional, Deleplanque, A.-S., additional, Fricker-Hidalgo, H., additional, Hadjadj, E., additional, Houze, S., additional, Ifrah, T., additional, Korobelnik, J.-F., additional, Labalette, P., additional, Le Lez, M.-Laure, additional, L’Ollivier, C., additional, Mercie, M., additional, Mouriaux, F., additional, Paris, L., additional, Pelloux, H., additional, Pomares, C., additional, Quintyn, J.-C., additional, Rougier, M.-B., additional, Rousseau, A., additional, Soler, V., additional, Talmud, M., additional, Villena, I., additional, Villard, O., additional, Speeg-Schatz, C., additional, Bourcier, T., additional, and Sauer, A., additional

Published
2022
Full Text
View/download PDF

44. Ocular inflammatory events following COVID-19 vaccination: a multinational case series

Author

Testi, I., Brandao-de-Resende, C., Agrawal, R., Pavesio, C., Steeples, L., Balasubramaniam, B., Mccluskey, P., Pichi, F., Agarwal, A., Herbort, C., Cimino, L., Iriqat, S., Thorne, J. E., Echegaray, J., Babu, K., Bialasiewicz, A. A., Goldstein, D. A., Ghadiri, N., Calduch, A. F., Andrade, G. C., Mahendradas, P., Gonzalez-Lopez, J. J., Carreno, E., Hamam, R. N., Stubiger, N., Bodaghi, B., Chao, Y. -J., Takeuchi, M., Tay-Kearney, M. -L., Portero, A., Keino, H., Esteban-Ortega, M., Przezdziecka-Dolyk, J., Radosavljevic, A., Paredes, I., Ling, H. S., Kiong, W., Tien, M., X. L., Ng, Chee, S. P., Siak, J., Hernanz-Rodriguez, I., Menezo, V., Tappeiner, C., Cruz, F. M., Addison, P., Kuijpers, R., Vasconcelos-Santos, D. V., Lee Kong Chian School of Medicine (LKCMedicine), Tan Tock Seng Hospital, Singapore Eye Research Institute, Duke NUS Medical School, Surgical clinical sciences, and Ophtalmology - Eye surgery

Subjects
Immunomodulatory, SARS-CoV-2, Vaccination, Ocular inflammation, COVID-19, RE1-994, vaccination, infectious diseases, Coronavirus disease, Uveitis, Ophthalmology, Medicine [Science], Ocular Inflammation, Original Research
Abstract

Background Inflammatory adverse events following COVID-19 vaccination are being reported amidst the growing concerns regarding vaccine’s immunogenicity and safety, especially in patients with pre-existing inflammatory conditions. Methods Multinational case series of patients diagnosed with an ocular inflammatory event within 14 days following COVID-19 vaccination collected from 40 centres over a 3 month period in 2021. Results Seventy patients presented with ocular inflammatory events within 14 days following COVID-19 vaccination. The mean age was 51 years (range, 19–84 years). The most common events were anterior uveitis (n = 41, 58.6%), followed by posterior uveitis (n = 9, 12.9%) and scleritis (n = 7, 10.0%). The mean time to event was 5 days and 6 days (range, 1–14 days) after the first and second dose of vaccine, respectively. Among all patients, 36 (54.1%) had a previous history of ocular inflammatory event. Most patients (n = 48, 68.6%) were managed with topical corticosteroids. Final vision was not affected in 65 (92.9%), whereas 2 (2.9%) and 3 (4.3%) had reduction in visual acuity reduced by ≤3 lines and > 3 lines, respectively. Reported complications included nummular corneal lesions (n = 1, 1.4%), cystoid macular oedema (n = 2, 2.9%) and macular scarring (n = 2, 2.9%). Conclusion Ocular inflammatory events may occur after COVID-19 vaccination. The findings are based on a temporal association that does not prove causality. Even in the possibility of a causal association, most of the events were mild and had a good visual outcome.

Published
2022

47. Current ophthalmology practice patterns for syphilitic uveitis

Author

Genevieve, F Oliver, Roy, M Stathis, João, M Furtado, Tiago, E Arantes, Peter, J McCluskey, Janet, M Matthews, Justine, R Smith, Accorinti, M, Adan, A, Agarwal, A, Alieldin, R, Allegri, P, Alvarez, C, Androudi, S, Arevalo, Jf, Aubin, Mj, Babu, K, Barisani-Asenbauer, T, Barron, Z, Basu, S, Biswas, J, Bodaghi, B, Bursztyn, M, Jose Capella, M, Caspers, L, Chee, Sp, Cimino, L, Colombero, D, Concha Del Rio LE, Curi, All, Dacey, M, Das, D, Davis, J, Edwar, L, Errera, Mh, Finamor, Lp, Fonollosa, A, Fortin, E, Fraser-Bell, S, Funk, M, Garcia-Serrano, Jl, Garweg, J, Garza-Leon, M, George, A, Goldstein, D, Goto, H, Gottlieb, C, Guedes, M, Guex-Crosier, Y, Gurbaxani, A, Henry, C, Hooper, C, Hovland, T, Hwang, Ys, Invernizzi, A, Isa, H, Jodar-Marquez, M, Kansupada, K, Kawali, A, Kempen, Jh, Khairallah, M, Krag, S, Kuijpers, R, Laithwaite, J, Lee, St, Lefebvre, P, Lehoang, P, Lobo, Am, Mahendradas, P, Mccluskey, P, Mili-Boussen, I, Mochizuki, M, Moschos, M, Nascimento, H, Nguyen, J, Nguyen, Qd, O'Keefe, G, Oli Mohamed, S, Ozdal, P, Menendez Padron MI, Palestine, A, Paroli, Mp, Pavesio, C, Pichi, F, Pleyer, U, Przezdziecka-Dolyk, J, Rao, N, Rathinam, S, Ribeiro, M, Roy, M, O P, Sabat, Sandhu, Hs, Sittivarakul, W, Smith, J, Smith, W, Somkijrungroj, T, Sood, A, Suelves, A, Tay-Kearney, Ml, Teuchner, B, Thorne, J, Trittibach, P, Tugal-Tutkun, I, Unzueta-Medina, Ja, Santos Valadares ED, Van Os, L, Wells, J, Alvarez, By, Young, S, Zierhut, M., and Surgical clinical sciences

Subjects
Adult, Male, syphilis, Penicillins, EYE, Eye Infections, Bacterial, Uveitis, 03 medical and health sciences, Cellular and Molecular Neuroscience, 0302 clinical medicine, Copyright policy, Surveys and Questionnaires, medicine, Humans, 030212 general & internal medicine, Practice Patterns, Physicians', Referral and Consultation, Societies, Medical, Retrospective Studies, Medicine(all), Practice patterns, business.industry, Middle Aged, medicine.disease, infection, Sensory Systems, Anti-Bacterial Agents, Syphilis Serodiagnosis, 3. Good health, Ophthalmology, inflammation, eye, uveitis, 030221 ophthalmology & optometry, Optometry, Female, Syphilis, business
Abstract

BackgroundSyphilitic uveitis is re-emerging alongside the systemic infection. In July 2017, an international group of uveitis-specialised ophthalmologists formed the International Ocular Syphilis Study Group to define current practice patterns.Methods103 Study Group members based in 35 countries completed a 25-item questionnaire focused on case load, clinical presentations, use and interpretation of investigations, treatment and clinical indicators of poor prognosis.ResultsMembers managed a mean of 6.1 patients with syphilitic uveitis in clinics that averaged 707 annual cases of uveitis (0.9%); 53.2% reported increasing numbers over the past decade. Patients presented to more members (40.2%) during secondary syphilis. Uveitis was usually posterior (60.8%) or pan (22.5%); complications included optic neuropathy, macular oedema and posterior synechiae. All members diagnosed syphilitic uveitis using serological tests (simultaneous or sequential testing algorithms), and 97.0% routinely checked for HIV co-infection. Cerebrospinal fluid (CSF) analysis was ordered by 90.2% of members, and 92.7% took uveitis plus Venereal Disease Research Laboratory test (VDRL) or fluorescent treponemal antibody absorption test (FTA-ABS) to indicate neurosyphilis. Patients were commonly co-managed with infectious disease physicians, and treated with penicillin for at least 10–14 days, plus corticosteroid. Features predicting poor outcome included optic neuropathy (86.3%) and initial misdiagnosis (63.7%). Reasons for delayed diagnosis were often practitioner-related. 82.5% of members tested every patient they managed with uveitis for syphilis.ConclusionThis comprehensive report by an international group of uveitis-specialised ophthalmologists provides a current approach for the management of syphilitic uveitis.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results